• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Vital Images extends Toshiba agreement

Article

The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed

The symbiotic relationship between Vital Images and Toshiba Medical Systems will continue under a U.S. and international marketing and distribution agreement that extends Toshiba's right to offer Vital Images' Vitrea 2 software. Toshiba has distributed the software since 2000 through its subsidiaries and distributors in more than 50 nations in North and South America, Europe, the Middle East, Africa, Australia, and Asia, excluding Japan. The 3D medical imaging product is sold primarily as an adjunct to Toshiba's Aquilion and Asteon CT scanners. The new agreement includes a minimum worldwide revenue commitment from Toshiba of $7.7 million and is effective through Dec. 31, 2004. At the RSNA meeting, Vital Images demonstrated Vitrea version 3.4 offering enhanced 3D visualization and analysis tools, including automated tools for examining vasculature.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.